The Digest: June 2025
In this month's news, a slew of 510(k) clearances, Boston Scientific pulls TAVR devices, Medtronic spins out diabetes division, and more.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueIn this month's news, a slew of 510(k) clearances, Boston Scientific pulls TAVR devices, Medtronic spins out diabetes division, and more.
A controversial set of papers in The British Medical Journal challenging the efficacy of common interventions for chronic low back pain reflects glaring gaps in treatment of a condition that affects millions, but industry has yet to commit substantial resources to addressing the underlying problems.
We present selected private financings for May and June, including Alpheus Medical's over-subscribed $50 million Series B round to support its randomized controlled clinical trial on its novel sonodynamic therapy for glioblastoma. Plus a snapshot of our featured cancer impact investor, ACS BrightEdge.